About
Activus Pure Nanoparticle Technology
Areas of Focus
Categories
BiosimilarsSmall Molecule PharmaceuticalTaiwan
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
913
By Phase
PHASE3: 2PHASE2: 1
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT04810962Lead Sponsor
Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study
PHASE3Completed
370 participants
Started: Mar 16, 2021 · Completed: Jul 6, 2022
NCT04739709Lead Sponsor
Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery
PHASE3Completed
378 participants
Started: Jan 11, 2021 · Completed: Mar 17, 2022
NCT04089735Lead Sponsor
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery
PHASE2Completed
165 participants
Started: Aug 13, 2019 · Completed: Apr 7, 2020
Locations (1)
Headquarters
Taipei, Taiwan
Map
Loading map...